APA (7th ed.) Citation

Stegeman, R., Nijman, M., Breur, J. M. P. J., Groenendaal, F., Haas, F., Derks, J. B., . . . consortium, C. t. (2022). CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): Study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trial. Trials, 23(1), 1. https://doi.org/10.1186/s13063-022-06098-y

Chicago Style (17th ed.) Citation

Stegeman, Raymond, et al. "CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): Study Protocol of a Phase III, Randomized, Quadruple-blinded, Placebo-controlled, Dutch Multicenter Trial." Trials 23, no. 1 (2022): 1. https://doi.org/10.1186/s13063-022-06098-y.

MLA (9th ed.) Citation

Stegeman, Raymond, et al. "CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): Study Protocol of a Phase III, Randomized, Quadruple-blinded, Placebo-controlled, Dutch Multicenter Trial." Trials, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s13063-022-06098-y.